Vnitr Lek 2020, 66(5):e26-e32 | DOI: 10.36290/vnl.2020.094

Confocal laser endomicroscopy in the diagnostics of esophageal diseases: a pilot study

Lumír Kunovský1,2, Zdeněk Kala2, Radek Kroupa1, Tomáš Grolich2, Jiří Dolina1, Milan Dastych1, Jitka Vaculová1, Jakub Vlažný3, Petr Moravčík2, Lydie Izakovičová Hollá4,5, Petra Bořilová Linhartová4,5, Petr Jabandžiev6, Vladimir Procházka2
1 Department of Gastroenterology and Internal Medicine, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic
2 Department of Surgery, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic
3 Department of Pathology, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic
4 Department of Pathophysiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
5 Clinic of Stomatology, St. Anne's Faculty Hospital, Faculty of Medicine, Masaryk University, Brno, Czech Republic
6 Department of Pediatrics, University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic

Background: Probe‑based confocal laser endomicroscopy (pCLE) is a novel diagnostic technique for endoscopy which enables a microscopic view at a cellular resolution in real‑time. Endoscopic detection of early neoplasia in the distal esophagus is difficult and often these lesions can be missed. The aim of the pilot study was to obtain characteristic pCLE figures in esophageal diseases for following studies, and to evaluate the possible future role of pCLE in the diagnostics of dysplastic Barrett's esophagus (BE) or early esophageal adenocarcinoma (EAC).

Methods: A review of the current literature was performed and previously published pCLE images and classifications of esophageal diseases were searched and studied first. In phase two of the pilot study patients with esophageal diseases such as reflux esophagitis, BE and EAC were enrolled and scheduled for upper endoscopy with pCLE. A healthy cohort was also included.

Results: From January 2019 to July 2019, a total of 14 patients were enrolled in this prospective pilot study: 3 patients with reflux esophagitis, 4 with BE, 3 with EAC and 4 persons were included in the healthy cohort. The endoscopy with pCLE was performed and characteristic pCLE figures were obtained. The correct diagnoses based on real‑time pCLE were evaluated by an endoscopist in 11 of the 14 cases (78.6 %).

Conclusion: It was possible to obtain typical pCLE images of esophageal diseases during a standard cap‑assisted endoscopic procedure. pCLE seems to be a feasible new technique in BE surveillance and early neoplastic lesion detection. However, more studies and data on larger number of patients are needed.

Keywords: Barrett's esophagus, confocal laser endomicroscopy, esophageal cancer, esophagitis.

Published: August 1, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kunovský L, Kala Z, Kroupa R, Grolich T, Dolina J, Dastych M, et al.. Confocal laser endomicroscopy in the diagnostics of esophageal diseases: a pilot study. Vnitr Lek. 2020;66(5):e26-32. doi: 10.36290/vnl.2020.094.
Download citation

References

  1. Desai TK, Krishnan K, Samala N et al. The incidence of oesophageal adenocarcinoma in non‑dysplastic Barrett's oesophagus: a meta‑analysis. Gut 2012; 61: 970-976. Go to original source... Go to PubMed...
  2. Dolak W, Mesteri I, Asari R et al. A pilot study of the endomicroscopic assessment of tumor extension in Barrett's esophagus-associated neoplasia before endoscopic resection. Endosc Int Open 2015; 3: E19-E28. Go to original source... Go to PubMed...
  3. Weusten B, Bisschops R, Coron E et al. Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy 2017; 49: 191-198. Go to original source... Go to PubMed...
  4. Schölvinck DW, van der Meulen K, Bergman JJGHM et al. Detection of lesions in dysplastic Barrett's esophagus by community and expert endoscopists. Endoscopy 2017; 49: 113-120. Go to original source... Go to PubMed...
  5. Rastogi A, Puli S, El‑Serag HB et al. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high‑grade dysplasia: a meta‑analysis. Gastrointest Endosc 2008; 67: 394-398. Go to original source... Go to PubMed...
  6. Naini BV, Souza RF, Odze RD Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists. Am J Surg Pathol 2016; 40: e45-e66. Go to original source... Go to PubMed...
  7. Wallace M, Lauwers GY, Chen Y et al. Miami classification for probe‑based confocal laser endomicroscopy. Endoscopy 2011; 43: 882-891. Go to original source... Go to PubMed...
  8. Gaddam S, Mathur SC, Singh M et al. Novel probe‑based confocal laser endomicroscopy criteria and interobserver agreement for the detection of dysplasia in Barrett's esophagus. Am J Gastroenterol 2011; 106: 1961-1969. Go to original source...
  9. di Pietro M, Bertani H, O'Donovan M et al. Development and Validation of Confocal Endomicroscopy Diagnostic Criteria for Low‑Grade Dysplasia in Barrett's Esophagus. Clin Transl Gastroenterol 2019; 10: e00014. Go to original source... Go to PubMed...
  10. Moravčík P, Hlavsa J, Kunovský L et al. Confocal Laser Endomicroscopy in the Diagnostics of Malignancy of the Gastrointestinal Tract. Klin Onkol 2017; 30: 258-263. Go to original source... Go to PubMed...
  11. Fuks D, Pierangelo A, Validire P et al. Intraoperative confocal laser endomicroscopy for real‑time in vivo tissue characterization during surgical procedures. Surg Endosc 2019; 33: 1544-1552. Go to original source... Go to PubMed...
  12. Sharma P, Meining AR, Coron E et al. Real‑time increased detection of neoplastic tissue in Barrett's esophagus with probe‑based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial. Gastrointest Endosc 2011; 74: 465-472. Go to original source... Go to PubMed...
  13. Canto MI, Anandasabapathy S, Brugge W et al. In vivo endomicroscopy improves detection of Barrett's esophagus‑related neoplasia: a multicenter international randomized controlled trial (with video). Gastrointest Endosc 2014; 79: 211-221. Go to original source... Go to PubMed...
  14. Shah T, Lippman R, Kohli D et al. Accuracy of probe‑based confocal laser endomicroscopy (pCLE) compared to random biopsies during endoscopic surveillance of Barrett's esophagus. Endosc Int Open 2018; 6: E414-E420. Go to original source... Go to PubMed...
  15. Kariv R, Plesec TP, Goldblum JR et al. The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol. Clin Gastroenterol Hepatol 2009; 7: 653-658. Go to original source... Go to PubMed...
  16. Caillol F, Godat S, Poizat F et al. Probe confocal laser endomicroscopy in the therapeutic endoscopic management of Barrett's dysplasia. Ann Gastroenterol 2017; 30: 295-301. Go to original source... Go to PubMed...
  17. Siegel R, Naishadham D, Jemal A Cancer statistics, 2012 CA Cancer J Clin 2012; 62: 10-29. Go to original source... Go to PubMed...
  18. Hur C, Miller M, Kong CY et al. Trends in esophageal adenocarcinoma incidence and mortality. Cancer 2013; 119: 1149-1158. Go to original source... Go to PubMed...
  19. Falk GW Barrett's Esophagus: Frequency and Prediction of Dysplasia and Cancer. Best Pract Res Clin Gastroenterol 2015; 29: 125-138.
  20. Domper Arnal MJ, Ferrández Arenas Á, Lanas Arbeloa Á Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol 2015; 21: 7933-7943. Go to original source... Go to PubMed...
  21. Svoboda P, Dítě P, Klvaňa P et al. Risk factors and progression predictors of Barrett's oesophagus to adenocarcinoma. Vnitř Lék 2014; 60: 467-473. Go to PubMed...
  22. Pech O, Gossner L, Manner H et al. Prospective evaluation of the macroscopic types and location of early Barrett's neoplasia in 380 lesions. Endoscopy 2007; 39: 588-593. Go to original source... Go to PubMed...
  23. Kariyawasam VC, Bourke MJ, Hourigan LF et al. Circumferential location predicts the risk of high‑grade dysplasia and early adenocarcinoma in short‑segment Barrett's esophagus. Gastrointest Endosc 2012; 75: 938-944. Go to original source... Go to PubMed...
  24. Pohl H, Wrobel K, Bojarski C et al. Risk factors in the development of esophageal adenocarcinoma. Am J Gastroenterol 2013; 108: 200-207. Go to original source... Go to PubMed...
  25. Anaparthy R, Gaddam S, Kanakadandi V et al. Association between length of Barrett's esophagus and risk of high‑grade dysplasia or adenocarcinoma in patients without dysplasia. Clin Gastroenterol Hepatol 2013; 11: 1430-1436. Go to original source... Go to PubMed...
  26. Richardson C, Colavita P, Dunst C et al. Real‑time diagnosis of Barrett's esophagus: a prospective, multicenter study comparing confocal laser endomicroscopy with conventional histology for the identification of intestinal metaplasia in new users. Surg Endosc 2019; 33: 1585-1591. Go to original source... Go to PubMed...
  27. Fitzgerald RC, di Pietro M, Ragunath K et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut 2014; 63: 7-42. Go to original source... Go to PubMed...
  28. Shaheen NJ, Sharma P, Overholt BF et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 2009; 360: 2277-2288. Go to original source... Go to PubMed...
  29. Kroupa R, Konečný Š, Dolina J Current trends in the diagnosis and treatment of gastroesophageal reflux disease. Vnitř Lék 2018; 64: 588-594. Go to original source... Go to PubMed...
  30. Martínek J, Falt P, Gregar J et al. Guidelines of the Czech gastroenterological society -endoscopic treatment of Barrett's esophagus and early esophageal neoplasia. Gastroent Hepatol 2013; 67: 479-487.
  31. Leers JM, DeMeester SR, Oezcelik A et al. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens. Ann Surg 2011; 253: 271-278. Go to original source... Go to PubMed...
  32. Pimentel‑Nunes P, Dinis‑Ribeiro M, Ponchon T et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47: 829-854. Go to original source... Go to PubMed...
  33. Lin JL T1 esophageal cancer, request an endoscopic mucosal resection (EMR) for in‑depth review. J Thorac Dis 2013; 5: 353-356. Go to PubMed...
  34. Barbour AP, Jones M, Brown I et al. Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors. Ann Surg Oncol 2010; 17: 2494-2502. Go to original source... Go to PubMed...
  35. Xiong YQ, Ma SJ, Zhou JH et al. A meta‑analysis of confocal laser endomicroscopy for the detection of neoplasia in patients with Barrett's esophagus. J Gastroenterol Hepatol 2016; 31: 1102-1110. Go to original source... Go to PubMed...
  36. Xiong YQ, Ma SJ, Hu HY et al. Comparison of narrow‑band imaging and confocal laser endomicroscopy for the detection of neoplasia in Barrett's esophagus: A meta‑analysis. Clin Res Hepatol Gastroenterol 2018; 42: 31-39. Go to original source... Go to PubMed...
  37. Wallace MB, Meining A, Canto MI et al. The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract. Aliment Pharmacol Ther 2010; 31: 548-552. Go to original source... Go to PubMed...
  38. Groof J de, van der Sommen F, van der Putten J et al. The Argos project: The development of a computer‑aided detection system to improve detection of Barrett's neoplasia on white light endoscopy. United Eur Gastroenterol J 2019; 7: 538-547. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.